Establishment of a simple and efficient platform for car-t cell generation and expansion: from lentiviral production to in vivo studies | Hematology, Transfusion and Cell Therapy
JCI Insight - A rational mouse model to detect on-target, off-tumor CAR T cell toxicity
Optimized gene engineering of murine CAR-T cells reveals the beneficial effects of IL-15 coexpression | Journal of Experimental Medicine | Rockefeller University Press
CAR T-cell Therapy for Osteosarcoma (OSCAR) – Inven2
A mouse model of CRS recapitulates clinical CAR T cell-induced CRS.... | Download Scientific Diagram
Logic-gated CAR-T cells safely target distant tumor cells
Steering CAR T Cells into Solid Tumors | NEJM
Cancers | Free Full-Text | Humanized Mice Are Precious Tools for Preclinical Evaluation of CAR T and CAR NK Cell Therapies
Modeling anti-CD19 CAR T cell therapy in humanized mice with human immunity and autologous leukemia - ScienceDirect
Nanobody-based CAR T cells that target the tumor microenvironment inhibit the growth of solid tumors in immunocompetent mice | PNAS
Therapeutic efficacy of anti-CD19 CAR-T cells in a mouse model of systemic lupus erythematosus | Cellular & Molecular Immunology
Therapeutic efficacy of anti-CD19 CAR-T cells in a mouse model of systemic lupus erythematosus | Cellular & Molecular Immunology
Custom CAR-T Development | AMSBIO
Enhancement of the in vivo persistence and antitumor efficacy of CD19 chimeric antigen receptor T cells through the delivery of modified TERT mRNA | Cell Discovery
JCI Insight - Pancreatic cancer therapy with combined mesothelin-redirected chimeric antigen receptor T cells and cytokine-armed oncolytic adenoviruses
CAR T cells cause CRS in HuSGM3 mice a, Eight-week-old SGM3 mice were... | Download Scientific Diagram
Long-term in vivo microscopy of CAR T cell dynamics during eradication of CNS lymphoma in mice | PNAS
Direct Delivery of piggyBac CD19 CAR T Cells Has Potent Anti-tumor Activity against ALL Cells in CNS in a Xenograft Mouse Model: Molecular Therapy - Oncolytics
Analysis and Augmentation of the Immunologic Bystander Effects of CAR T Cell Therapy in a Syngeneic Mouse Cancer Model - ScienceDirect
Preclinical Models in Chimeric Antigen Receptor–Engineered T-Cell Therapy | Human Gene Therapy
CD5 CAR T cells control progression of T-ALL in xenograft mouse models.... | Download Scientific Diagram
